<!DOCTYPE html><html lang="en">
<head>
<title>SampleEnd &lt; CTSpedia &lt; Foswiki</title>
<meta http-equiv="X-UA-Compatible" content="IE=edge" />
<meta charset="utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1.5, user-scalable=yes" />
<meta name="mobile-web-app-capable" content="yes" />
<meta name="mobile-web-app-status-bar-style" content="black-translucent" />
<meta name="apple-mobile-web-app-capable" content="yes" />
<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent" />
<link type="image/x-icon" href="../MISSING RESOURCE CTSpedia/SampleEnd/favicon.ico" rel="icon"> <link href="../MISSING RESOURCE CTSpedia/SampleEnd/favicon.ico" rel="shortcut icon" type="image/x-icon">
<link rel="alternate" href="SampleEnd.html" title="edit SampleEnd" type="application/x-wiki">
<meta name="description" content="SampleEnd" />
<link type="text/css" href="../System/SmiliesPlugin.attachments/smilies.css" class="head SMILIESPLUGIN" media="all" rel="stylesheet"><!--SMILIESPLUGIN-->
<style class='head TABLEPLUGIN_default' type="text/css" media="all">
body .foswikiTable {border-width:1px}
body .foswikiTable .tableSortIcon img {padding-left:.3em; vertical-align:text-bottom}
body .foswikiTable td {border-style:solid none; vertical-align:top}
body .foswikiTable th {border-style:none solid; vertical-align:top; background-color:#d6d3cf; color:#000000}
body .foswikiTable th a:link {color:#000000}
body .foswikiTable th a:visited {color:#000000}
body .foswikiTable th a:hover {color:#000000; background-color:#d6d3cf}
body .foswikiTable th.foswikiSortedCol {background-color:#c4c1ba}
body .foswikiTable tr.foswikiTableRowdataBg0 td {background-color:#ffffff}
body .foswikiTable tr.foswikiTableRowdataBg0 td.foswikiSortedCol {background-color:#f7f7f6}
body .foswikiTable tr.foswikiTableRowdataBg1 td {background-color:#f7f7f6}
body .foswikiTable tr.foswikiTableRowdataBg1 td.foswikiSortedCol {background-color:#f0f0ee}
</style><!--TABLEPLUGIN_default-->
<script src="../System/JQueryPlugin.attachments/jquery-2.2.4.js" class="script JQUERYPLUGIN"></script><!--JQUERYPLUGIN-->
<script src="../System/JQueryPlugin.attachments/plugins/observer/observer.js?version=0.1" class="script JQUERYPLUGIN::OBSERVER"></script><!--JQUERYPLUGIN::OBSERVER-->
<script src="../System/JQueryPlugin.attachments/plugins/migrate/jquery.migrate.js?version=3.3.1" class="script JQUERYPLUGIN::MIGRATE"></script><!--JQUERYPLUGIN::MIGRATE-->
<script class="script JQUERYPLUGIN::FOSWIKI" src="../System/JQueryPlugin.attachments/plugins/foswiki/jquery.foswiki.js?version=3.01"></script><!--JQUERYPLUGIN::FOSWIKI-->
<script src="../System/JQueryPlugin.attachments/plugins/browser/jquery.browser.js?version=0.1.0" class="script JQUERYPLUGIN::BROWSER"></script><!--JQUERYPLUGIN::BROWSER-->
<script class='script JQUERYPLUGIN::FOSWIKI::PREFERENCES foswikiPreferences' type='text/json'>{
   "SCRIPTURL" : "http://biostat1478.dhcp.mc.vanderbilt.edu/foswiki/bin",
   "SYSTEMWEB" : "System",
   "URLHOST" : "http://biostat1478.dhcp.mc.vanderbilt.edu",
   "PUBURL" : "http://biostat1478.dhcp.mc.vanderbilt.edu/foswiki/pub",
   "COOKIEREALM" : "",
   "WIKINAME" : "WikiAdmin",
   "SKIN" : "natedit,pattern",
   "SCRIPTURLPATH" : "/foswiki/bin",
   "SCRIPTSUFFIX" : "",
   "WIKIUSERNAME" : "Main.WikiAdmin",
   "USERSWEB" : "Main",
   "TOPIC" : "SampleEnd",
   "SERVERTIME" : "08 Feb 2023 - 15:50",
   "WEB" : "CTSpedia",
   "SCRIPTURLPATHS" : {},
   "NAMEFILTER" : "[\\\\\\s*?~^$@%`\"'&|<:;>\\[\\]#\\x00-\\x1f]",
   "PUBURLPATH" : "/foswiki/pub",
   "USERNAME" : "WikiAdmin"
}
</script><!--JQUERYPLUGIN::FOSWIKI::PREFERENCES-->
</head>
<body>
<h1 id="Case_Control_Design_45_Sampling_Controls_at_Follow_45up">  Case Control Design - Sampling Controls at Follow-up </h1>
 <strong><em>Lead Author(s):</em></strong> Jeff Martin, MD 
<div class="foswikiToc" id="foswikiTOC"> <ul>
<li> <a href="#Summary_of_Case_45Control_Sampling"> Summary of Case-Control Sampling </a>
</li> <li> <a href="#Definition_of_Prevalent_Controls"> Definition of Prevalent Controls </a>
</li> <li> <a href="#Diagram_Using_Prevalent_Controls_at_Follow_45up"> Diagram Using Prevalent Controls at Follow-up </a>
</li> <li> <a href="#Problems_with_Using_Prevalent_Controls_at_Follow_45up"> Problems with Using Prevalent Controls at Follow-up </a>
</li> <li> <a href="#Limitation_of_Study_Controls_45FIRST_PROBLEM"> Limitation of Study Controls-FIRST PROBLEM </a>
</li> <li> <a href="#Bias_in_Waiting_until_Follow_45up_45_SECOND_PROBLEM"> Bias in Waiting until Follow-up- SECOND PROBLEM </a>
</li> <li> <a href="#Inability_to_Calculate_the_Risk_Ratio_45THIRD_PROBLEM"> Inability to Calculate the Risk Ratio -THIRD PROBLEM </a> <ul>
<li> <a href="#Example_of_Inability_to_Calculate_the_Risk_Ratio"> Example of Inability to Calculate the Risk Ratio </a>
</li> <li> <a href="#Example_Showing_Incorrect_Odds_Ratio"> Example Showing Incorrect Odds Ratio </a>
</li></ul> 
</li> <li> <a href="#Prevalent_Controls_45_Rare_Disease_Assumption_45FOURTH_PROBLEM"> Prevalent Controls - Rare Disease Assumption-FOURTH PROBLEM </a>
</li> <li> <a href="#Case_Control_with_Low_Incidence_45PROBLEM"> Case Control with Low Incidence-PROBLEM </a> <ul>
<li> <a href="#Example_of_Case_Control_with_Low_Incidence"> Example of Case Control with Low Incidence </a>
</li></ul> 
</li> <li> <a href="#CAVEAT:_Sampling_Non_45cases_May_Introduce_Bias_45PROBLEM"> CAVEAT: Sampling Non-cases May Introduce Bias-PROBLEM </a>
</li></ul> 
</div>
<p></p>
<h2 id="Summary_of_Case_45Control_Sampling">  Summary of Case-Control Sampling </h2>
<table class="foswikiTable" rules="none">
	<thead>
		<tr class="foswikiTableOdd foswikiTableRowdataBgSorted0 foswikiTableRowdataBg0">
			<th class="foswikiTableCol0 foswikiFirstCol"> <a title="Sort by this column" href="../PublishPlugin/publish.html" rel="nofollow">Design</a> </th>
			<th class="foswikiTableCol1"> <a title="Sort by this column" rel="nofollow" href="../PublishPlugin/publish.html">Sampling</a> </th>
			<th class="foswikiTableCol2 foswikiLastCol"> <a title="Sort by this column" href="../PublishPlugin/publish.html" rel="nofollow">Measure of Association</a> </th>
		</tr>
	</thead>
	<tbody>
		<tr class="foswikiTableEven foswikiTableRowdataBgSorted0 foswikiTableRowdataBg0">
			<td class="foswikiTableCol0 foswikiFirstCol"> <a href="SampleBaseline.html">Case-cohort</a> </td>
			<td class="foswikiTableCol1"> Entire cohort at baseline </td>
			<td class="foswikiTableCol2 foswikiLastCol"> <a href="RiskRatio.html">risk ratio</a> </td>
		</tr>
		<tr class="foswikiTableOdd foswikiTableRowdataBgSorted1 foswikiTableRowdataBg1">
			<td class="foswikiTableCol0 foswikiFirstCol"> <a href="SampleIncidence.html">Incidence-density</a> </td>
			<td class="foswikiTableCol1"> Non-cases at time of diagnosis </td>
			<td class="foswikiTableCol2 foswikiLastCol"> <a href="RateRatio.html">rate ratio</a> </td>
		</tr>
		<tr class="foswikiTableEven foswikiTableRowdataBgSorted0 foswikiTableRowdataBg0">
			<td class="foswikiTableCol0 foswikiFirstCol foswikiLast"> Prevalent Case Control </td>
			<td class="foswikiTableCol1 foswikiLast"> Non-cases at single point in time </td>
			<td class="foswikiTableCol2 foswikiLastCol foswikiLast"> <p><a href="OddsTerm.html">odds ratio</a></p><p> </p><p> </p> </td>
		</tr>
	</tbody></table>
<p></p> <ul>
<li> <strong>A random sample of the cohort baseline</strong> = <strong>case-cohort design</strong>  <ul>
<li> (<a href="SampleBaseline.html">Sampling Controls - Random Sample at Baseline</a>)
</li></ul> 
</li></ul> 
<p></p> <ul>
<li> <strong>At time each case is diagnosed</strong> = <strong>incidence density sampling</strong>  <ul>
<li> (<a href="SampleIncidence.html">Sampling Controls - Incidence Density Sampling</a>)
</li></ul> 
</li></ul> 
<p></p> <ul>
<li> <strong>From persons without disease at the end of follow-up</strong> = <strong>prevalent controls design</strong>
</li></ul> 
<p></p>
<h2 id="Definition_of_Prevalent_Controls">  Definition of Prevalent Controls </h2>
 Sampling only non-cases in a primary or secondary <a href="StudyBase.html">study base</a>
<p></p>
This case-control design uses <strong>prevalent <a href="StudyControl.html">controls</a> at <a href="FollowUpTime.html">follow-up </a></strong>. <ul>
<li> Called prevalent controls because controls are sampled from those without <a href="OutcomeVariable.html">disease</a> with a <a href="CrossSectionalStudy.html">cross-sectional sample</a> of the <a href="StudyBase.html">study base</a>
</li></ul> 
<a href="OddsTerm.html">Odds ratio approximates risk ratio</a> only if disease occurrence is rare
<p></p>
This sampling is the classic instance of needing the <strong><a href="OddsTerm.html">rare disease assumption</a></strong> assumption that many text books discuss <ul>
<li> because the OR will approximate the risk ratio only if the incidence is low or rare.
</li></ul> 
<p></p>
<h2 id="Diagram_Using_Prevalent_Controls_at_Follow_45up">  Diagram Using Prevalent Controls at Follow-up </h2>
 In the diagram below, one can see prevalent controls drawn from the non-diseased individuals at follow-up. <blockquote>
<p></p>
<img src="SampleEnd.attachments/0527_1_prevalent.JPG" alt="0527_1_prevalent.JPG" height="154" width="218">
</blockquote>
<p></p>
<h2 id="Problems_with_Using_Prevalent_Controls_at_Follow_45up">  Problems with Using Prevalent Controls at Follow-up </h2>
 This is the design that most neophytes are drawn to. It is the least desirable of the three types of control sampling but it used to be the most common. That may no longer be the case as researchers are becoming more sophisticated about <a href="CaseControlStudy.html">case-control design</a>.
<p></p>
LIST PROBLEMS AND LINK
<p></p>
<h2 id="Limitation_of_Study_Controls_45FIRST_PROBLEM">  Limitation of Study Controls-FIRST PROBLEM </h2>
 So even if all the <a href="StudyCase.html">cases</a> are captured as in the schematic,  <ul>
<li> the <a href="StudyControl.html">controls</a> are drawn <strong>only from those present at the time the study</strong> is conducted.
</li></ul> 
So unlike the case-cohort and the <a href="CaseControlStudy.html">case-control</a> with <a href="SampleIncidence.html">incidence density sampling</a> designs,  <ul>
<li> <strong>no <a href="StudyCase.html">cases</a> can be included in the <a href="StudyControl.html">control</a> group</strong>.
</li></ul> 
Because the cases are excluded,  <ul>
<li> <strong>the control group can no longer represent the entire baseline population of the cohort</strong>.
</li></ul> 
<h2 id="Bias_in_Waiting_until_Follow_45up_45_SECOND_PROBLEM">  Bias in Waiting until Follow-up- SECOND PROBLEM </h2>
 As you can see one of the problems with this design is that there is an obvious source of potential <a href="BiasDefinition.html">bias</a> in waiting until the end of <a href="FollowUpTime.html">follow-up</a> to select controls  <ul>
<li> because factors that influence loss to follow-up will influence the selection of controls.
</li></ul> 
Furthermore, losses to follow-up and deaths also make this group of controls not very representative of the population that gave rise to the cases.  <ul>
<li> Nor can it represent the <a href="StudyIncidence.html">person-time</a> of the cohort because time is not represented throughout the <a href="StudyBase.html">study base</a> experience in sampling the controls, only one time point is used.
</li></ul> 
<strong>If those factors are associated with both your <a href="PredictorVariable.html">predictor variable</a> and your <a href="OutcomeVariable.html">outcome</a>, the <a href="StudyAssoc.html">measure of association</a></strong> will be biased.
<p></p>
<h2 id="Inability_to_Calculate_the_Risk_Ratio_45THIRD_PROBLEM">  Inability to Calculate the Risk Ratio -THIRD PROBLEM </h2>
 In case control design, <a href="SampleBaseline.html">Case Control Design: OR equals RR</a>.
<p></p>
<img src="SampleEnd.attachments/0527_1_a_cases.JPG" height="59" alt="0527_1_a_cases.JPG" width="35"> <strong>ratio is known in all case-control designs</strong>
<p></p>
<strong>BUT sampling only non-cases cannot get unbiased estimate of</strong> <img alt="0527_1_b_N.JPG" height="59" src="SampleEnd.attachments/0527_1_b_N.JPG" width="35">
<p></p>
<strong>The ratio of exposed to unexposed in the whole cohort</strong> <ul>
<li> can only be estimated by a sample of everyone at the beginning of follow-up,
</li> <li> not just those who remain non-cases at the end of follow-up.
</li></ul> 
<p></p>
<h3 id="Example_of_Inability_to_Calculate_the_Risk_Ratio">  Example of Inability to Calculate the Risk Ratio </h3>
 <blockquote> <img alt="0324_2example.JPG" height="136" src="SampleEnd.attachments/0324_2example.JPG" width="257"> </blockquote> So using <strong>prevalent controls</strong>, you get:  <ul>
<li> 60 non-cases in the exposed
</li> <li> 90 non-cases in the unexposed
</li></ul> 
<blockquote><img src="SampleEnd.attachments/0324_3_eovere.JPG" height="139" alt="0324_3_eovere.JPG" width="234"></blockquote>
<p></p>
<h3 id="Example_Showing_Incorrect_Odds_Ratio">  Example Showing Incorrect Odds Ratio </h3>
 If you look at the <a href="OddsTerm.html">odds calculation</a>:
<p></p>
<strong>ad/bc</strong> = OR
<blockquote> <img width="278" src="SampleEnd.attachments/0324_4or.JPG" alt="0324_4or.JPG" height="114"> </blockquote> IN this example,
<p></p> <ul>
<li> <strong>(40 * 90) / (60 * 10) = 6.0</strong>
</li></ul> 
One quarter of the cohort has been diagnosed with disease during the cohort follow-up  <ul>
<li> l <strong>eaving only 150 of the original 200 left from which to select controls</strong> using the prevalent control case-control design.
</li></ul> 
Since the original cohort was divided 50/50 by exposure and the  <ul>
<li> <strong>odds of disease among exposed versus unexposed cases is 4 to 1</strong>,
</li> <li> the remaining subjects without disease will have a ratio of 60/90 or 2/3 of exposed to unexposed.
</li></ul> 
In other words, the odds of exposure in the eligible controls will be 2/3 and the odds ratio will be 4 divided by 2/3 = 6.0.
<p></p>
These numbers use everyone in the cohort and the case-control study will only use a sample of 150 remaining without disease but as they will be sampled independently of exposure status the ratio of 2/3 also applies to any random sample of controls.
<p></p>
<strong>Thus the OR in this example is much larger than the risk ratio and cannot be considered even an approximation of it</strong>.
<p></p>
<span id="RarePrevalent"></span>
<h2 id="Prevalent_Controls_45_Rare_Disease_Assumption_45FOURTH_PROBLEM">  Prevalent Controls - Rare Disease Assumption-FOURTH PROBLEM </h2>
<p></p>
<strong><em>If <a href="StudyControl.html">controls</a> are selected among those without <a href="OutcomeVariable.html">disease</a> at time of study (+/- prevalent cases), the <a href="OddsRatioMeasures.html">OR</a> approximates <a href="RiskRatio.html">risk ratio</a> only with the</em></strong> <ul>
<li> <strong><a title="Create this topic" href="CaseControlsOddsRatio.html" class="foswikiNewLink" rel="nofollow">rare disease assumption</a>.</strong>
</li></ul> 
<p></p>
<h2 id="Case_Control_with_Low_Incidence_45PROBLEM">  Case Control with Low Incidence-PROBLEM </h2>
 <img alt="0325_2sample.JPG" height="70" src="SampleEnd.attachments/0325_2sample.JPG" width="271">
<p></p>
If the disease only removes a few persons from the original <a href="StudyCohort.html">cohort</a>, <ul>
<li> the ratio of <a href="PredictorVariable.html">exposure</a> in those remaining will stay close to the original ratio at baseline.
</li></ul> 
It follows that estimating N0/N1 by using prevalent controls  <ul>
<li> becomes increasing more valid as the <strong>number removed by the disease gets smaller</strong>.
</li></ul> 
<p></p>
<h3 id="Example_of_Case_Control_with_Low_Incidence">  Example of Case Control with Low Incidence </h3>
 <blockquote> <img alt="0325_3_table.JPG" height="82" src="SampleEnd.attachments/0325_3_table.JPG" width="228"> </blockquote> IN this example,  <ul>
<li> <strong>(4 * 99) / (96 * 1) = 4.13</strong>
</li></ul> 
Assuming that the <a href="StudyIncidence.html">incidence of disease</a> was 2.5% (5 out of 200 developed disease),  <ul>
<li> the OR is only slightly higher than the risk ratio for the simple reason
</li> <li> that the ratio of exposure in the remaining non-cases is close to 1.0,  <ul>
<li> which is what it was in the whole cohort at baseline.
</li></ul> 
</li></ul> 
The somewhat arbitrary rule of thumb of incidence below 10% is sometimes given as what is meant by a <strong>rare disease</strong>
<p></p>
If the incidence were 10% (16 exposed cases and 4 unexposed cases), <ul>
<li> <strong>OR = 4.57</strong> (Do you think that this is a good approximation of 4.0?)
</li></ul> 
<p></p>
<h2 id="CAVEAT:_Sampling_Non_45cases_May_Introduce_Bias_45PROBLEM">  CAVEAT: Sampling Non-cases May Introduce Bias-PROBLEM </h2>
<p></p>
<strong><em>Disease may remove few from study base sampled for <a href="StudyControl.html">controls</a>, but other sources of loss to* *<a href="LostToFollowUp.html">loss to follow-up</a> can <a href="BiasDefinition.html">bias</a> control group.</em></strong>
<p></p> <ul>
<li> The rare disease assumption <strong>only looks at the effect of removing potential controls</strong> who are diagnosed with the <a href="OutcomeVariable.html">outcome, the disease</a>.
</li></ul> 
<strong><em>Losses to follow-up and deaths among potential controls from the <a href="StudyBase.html">study base</em></strong> <strong><em></a> givingrise to the <a href="StudyCase.html">cases</a> affect who is available at one point in time.</em></strong>
<p></p> <ul>
<li> Looking at the <a href="StudyBase.html">study base</a> that gave rise to those cases over time, some members of the study base population at time zero <strong>will not be in the population of non-cases</strong> sampled at the end of the time when all the cases have been ascertained. Some will have left the study base or died, and these changes in the group of non-cases who are sampled can <a href="BiasDefinition.html">bias</a>, the estimate of exposure in the controls. Since no information is available on who left the study base with the prevalent controls design, the nature of this bias cannot be known. Thus, even though the rare disease assumption is met, <strong>the OR from this type of case-control sampling may give a biased estimate of the risk ratio.</strong>
</li></ul> 
<p></p>
<hr />
 <strong><em><br /></em></strong>
<p></p>
<hr />
<p></p>
<hr />
<p></p>
</body>